President Trump lambastes Twitter, Google and other technology giants for what he claims as their efforts to repress his messaging.US Economyread more
JP Morgan's Jamie Dimon says student lending "is a disgrace and it's hurting America."Economyread more
Mnuchin tells CNBC he's confident President Trump and China's Xi Jinping can make progress in stalled trade talks.World Economyread more
The first debates will give most of the contenders their biggest platform yet to present themselves to the American people.Politicsread more
Underneath the impressive market rally is a trend that doesn't seem quite right, according to J.P. Morgan.Marketsread more
The stock market is shrinking for several key reasons, but there's a way for investors to maneuver it, says Citi Research strategist Robert Buckland.Trading Nationread more
The Supreme Court refused to overturn a precedent that strengthened the power of government regulators in a closely watched case that could have had broad ramifications for...Politicsread more
President Trump says "I hope we don't" have a war with Iran but it "would not last very long."Politicsread more
Stocks rose on Wednesday as comments from Treasury Secretary Steven Mnuchin lifted expectations of a potential trade deal between China and the U.S.Marketsread more
Presidents Donald Trump and Xi Jinping are scheduled to meet Saturday, the second day of the two-day G-20 summit in Osaka, Japan.Politicsread more
A small group of companies have gotten so big that they are essentially becoming the market, and when they do well, the markets do well.Trader Talk with Bob Pisaniread more
Former FDA Commissioner Scott Gottlieb said Friday that CBD can get users high — despite claims to the contrary.
CBD products are "flooding the market" since Congress approved the sale of CBD, or cannabidiol, derived from hemp last year, Gottlieb said in an interview on CNBC's "Squawk Box. " Hemp is in the marijuana family, but the CBD that comes from it doesn't have have the psychoactive ingredient Tetrahydrocannabinol (THC) that gets users high.
Gottlieb's comments come as the Food and Drug Administration holds its first public hearing Friday on CBD with testimony lined up from some 140 manufacturers, researchers, farmers, retailers and others.
"Don't think [CBD] can't make you high. The CBD derived from cannabis does have THC in it," Gottlieb said, noting that CBD that is manufactured from hemp does not share the same risk.
The Consumer Healthcare Products Association is lobbying the FDA to regulate CBD similar to Vitamin C, possibly establishing guidelines like dosage levels it deems safe for over-the-counter use. But Gottlieb said regulating CBD is tricky because it's so closely related to marijuana.
"It's going to be hard for regulators to differentiate between the CBD that's derived from cannabis versus the CBD that's derived from hemp," Gottlieb said. "What is derived from cannabis could have high levels of THC in it. The [drug-sniffing] dogs have a hard time differentiating as well."
Gottlieb formed a working group in April to evaluate how to regulate CBD and examine the potential risks, including its impact on the liver over time.
Friday's hearing, meantime, come as companies, including large food manufacturers, are pushing the government to regulate the industry so they can decide whether and how to get into it. The CEO of Oreo-owner Mondelez, Dirk Van de Put, has told CNBC it is eyeing adding CBD-infused snacks but "want to stay within what is legal and play it the right way."
Gottlieb said most of the products on the market today are, in fact, illegal.
"These big packaged food companies want to get into this business and right now there's no legal path. So they're reluctant to step forward. They're the ones putting pressure on the regulators," he said.
Disclosure: Former FDA Commissioner Scott Gottlieb is now a CNBC contributor.